A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS) — Stella
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(17 sites)
Argentina
INECO Neurociencias Orono, Rosario, Santa Fe Province
Sanatorio del Sur S.A., San Miguel de Tucumán
Brazil
L2IP ?Instituto de Pesquisas Clínicas Ltda., Brasília, Federal District
Instituto de Neurologia de Curitiba - Hospital Ecoville, Curitiba, Paraná
Nucleo de Pesquisa Clinica do Rio Grande do Sul NPCR, Porto Alegre, Rio Grande do Sul
Centro de Pesquisas Clinicas - CPCLIN, São Paulo, São Paulo
Mexico
Clinstile S.A de C.V., Mexico City, Mexico CITY (federal District)
Neurociencias Estudios Clinicos S.C., Culiacán, Sinaloa
Poland
Uniwersyteckie Centrum Kliniczne, Gdansk
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan
Instytut "Pomnik - Centrum Zdrowia Dziecka", Warsaw
Portugal
Centro Clnico Acadmico - Braga, Associao (2CA-Braga), Braga
Unidade Local de Saude de Coimbra E P E, Coimbra
Spain
Hospital Universitario de La Princesa, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario Virgen Macarena, Seville
Ukraine
CNE of Lviv Reg Clin Hospital Dept of Neurology D.Halytskyi Lviv NMU, Lviv, KIEV Governorate